These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial. ; Dear J Trials; 2019 Jan; 20(1):27. PubMed ID: 30621764 [TBL] [Abstract][Full Text] [Related]
8. Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review. Mullins ME; Yeager LH; Freeman WE Clin Toxicol (Phila); 2020 Dec; 58(12):1284-1296. PubMed ID: 32762579 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. McGill MR; Jaeschke H Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1005-17. PubMed ID: 24836926 [TBL] [Abstract][Full Text] [Related]
10. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Link SL; Rampon G; Osmon S; Scalzo AJ; Rumack BH Clin Toxicol (Phila); 2022 Apr; 60(4):472-477. PubMed ID: 34709101 [TBL] [Abstract][Full Text] [Related]
11. Use of fomepizole (4-methylpyrazole) for acetaminophen poisoning: A scoping review. Pourbagher-Shahri AM; Schimmel J; Shirazi FM; Nakhaee S; Mehrpour O Toxicol Lett; 2022 Feb; 355():47-61. PubMed ID: 34785186 [TBL] [Abstract][Full Text] [Related]
13. Central Mechanisms of Acetaminophen Hepatotoxicity: Mitochondrial Dysfunction by Protein Adducts and Oxidant Stress. Jaeschke H; Ramachandran A Drug Metab Dispos; 2024 Jul; 52(8):712-721. PubMed ID: 37567742 [TBL] [Abstract][Full Text] [Related]
14. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial). Morrison EE; Oatey K; Gallagher B; Grahamslaw J; O'Brien R; Black P; Oosthuyzen W; Lee RJ; Weir CJ; Henriksen D; Dear JW; EBioMedicine; 2019 Aug; 46():423-430. PubMed ID: 31311721 [TBL] [Abstract][Full Text] [Related]
16. Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase. Akakpo JY; Ramachandran A; Duan L; Schaich MA; Jaeschke MW; Freudenthal BD; Ding WX; Rumack BH; Jaeschke H Toxicol Sci; 2019 Jul; 170(1):57-68. PubMed ID: 30903181 [TBL] [Abstract][Full Text] [Related]
17. 4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes. Akakpo JY; Ramachandran A; Kandel SE; Ni HM; Kumer SC; Rumack BH; Jaeschke H Hum Exp Toxicol; 2018 Dec; 37(12):1310-1322. PubMed ID: 29739258 [TBL] [Abstract][Full Text] [Related]
18. Lack of mitochondrial Cyp2E1 drives acetaminophen-induced ER stress-mediated apoptosis in mouse and human kidneys: Inhibition by 4-methylpyrazole but not N-acetylcysteine. Akakpo JY; Ramachandran A; Rumack BH; Wallace DP; Jaeschke H Toxicology; 2023 Dec; 500():153692. PubMed ID: 38042273 [TBL] [Abstract][Full Text] [Related]
19. Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the Psi parameter. Chomchai S; Chomchai C Clin Toxicol (Phila); 2014 Jun; 52(5):506-11. PubMed ID: 24844577 [TBL] [Abstract][Full Text] [Related]
20. Liver Regeneration after Acetaminophen Hepatotoxicity: Mechanisms and Therapeutic Opportunities. Bhushan B; Apte U Am J Pathol; 2019 Apr; 189(4):719-729. PubMed ID: 30653954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]